A 58-year-old nurse from Scotland has died after taking two doses of weight-loss drug tirzepatide, also known as Mounjaro or ...

There's a new player in the running game, and it's not the latest carbon-plated shoe or fancy GPS watch. GLP-1 medications ...

People are more likely to develop type 2 diabetes if they are: Experts with UW Health say it is important to remember the ...

We rate McKesson as a 'Strong Buy' with focus on GLP-1 meds, oncology network, and strong Q2 results driving future growth.

The annual meeting of the American College of Gastroenterology was held from Oct. 25 to 30 in Philadelphia and attracted ...

Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Labels ...

With the American Heart Association (AHA) and American Stroke Association (ASA) updating their guidelines for preventing ...

There’s a new warning from the FDA on GLP-1 drugs including Ozempic and Wegovy. In general, when a person prepares for a ...

In October, the FDA removed Mounjaro and Zepbound—the diabetes and obesity GLP-1 drugs made by Eli Lilly—from the shortage ...

Researchers projected that more than 42,000 deaths could be averted annually, including more than 11,000 among those with type 2 diabetes.

Losing weight on GLP-1 drugs like Ozempic isn't guaranteed. Experts reveal how to tell if yours isn't working and the next steps you should take to reach your weight loss goals.